ELL anticorps
-
- Antigène Voir toutes ELL Anticorps
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ELL est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Réactivité croisée
- Humain, Souris
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogène
- Synthesized peptide derived from internal of Human ELL.
- Isotype
- IgG
- Top Product
- Discover our top product ELL Anticorps primaire
-
-
- Indications d'application
- WB:1:500-1:3000,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- ELL (Elongation Factor RNA Polymerase II (ELL))
- Autre désignation
- ELL (ELL Produits)
- Synonymes
- anticorps wu:fc60b11, anticorps zgc:63836, anticorps C19orf17, anticorps ELL1, anticorps MEN, anticorps PPP1R68, anticorps Ell1, anticorps Men, anticorps elongation factor for RNA polymerase II, anticorps elongation factor RNA polymerase II, anticorps ELL, anticorps ell, anticorps Ell
- Sujet
-
Background: Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. ELL also plays an early role before its assembly into in the SEC complex by stabilizing RNA polymerase II recruitment/initiation and entry into the pause site. Required to stabilize the pre-initiation complex and early elongation.
Thirman M.J., Proc. Natl. Acad. Sci. U.S.A. 91:12110-12114(1994).
Simone F., Blood 98:201-209(2001).
Kong S.E., Proc. Natl. Acad. Sci. U.S.A. 102:10094-10098(2005).Aliases: ELL antibody, C19orf17RNA polymerase II elongation factor ELL antibody, Eleven-nineteen lysine-rich leukemia protein antibody
- UniProt
- P55199
-